CellBion Co., Ltd. (KOSDAQ:308430)
South Korea · Delayed Price · Currency is KRW 18,310
+520 (2.92%)
At close: Jun 12, 2026
CellBion Market Cap
CellBion has a market cap or net worth of 236.3 billion as of June 12, 2026. Its market cap has increased by 4.88% in one year.
Market Cap
236.30B
Enterprise Value
224.39B
Revenue
2.08B
Ranking
n/a
PE Ratio
n/a
Stock Price
18,310.00
Market Cap Chart
Since October 16, 2024, CellBion's market cap has decreased from 263.06B to 236.30B, a decrease of -10.17%. That is a compound annual growth rate of -6.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 236.30B | -21.97% |
| Dec 30, 2025 | 302.82B | 100.48% |
| Dec 30, 2024 | 151.05B | -42.58% |
| Oct 16, 2024 | 263.06B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ImmuneOncia Therapeutics | 381.06B |
| Samyang Biopharm | 367.33B |
| HEM Pharma | 304.63B |
| NOVAREX | 253.04B |
| Vivozon Pharmaceutical | 236.15B |
| DAE HWA Pharmaceutical | 187.78B |
| High Tech Pharm | 153.12B |
| GC WellBeing | 142.57B |